Market Overview

UPDATE: Jefferies Raises PT on CME Group on 1Q13 Exchange Preview

Related CME
Investors Rewarded With Treats, Not Tricks, As Dow And S&P Close At Record Highs
Earnings Scheduled For October 30, 2014
CME Glitch Halts Electronic Trading in Some Commodities (Fox Business)

In a report published Monday, Jefferies analyst Daniel T. Fannon reiterated a Buy rating on CME Group (NASDAQ: CME), and raised the price target from $65.00 to $69.00.

In the report, Fannon noted, “We have lowered our 1Q13 EPS expectations for the traditional equity exchanges, while our numbers for the derivatives exchanges remain relatively unchanged. This mirrors the state of general industry trends, where the outlook for derivatives volume growth is much stronger than equity volume growth. CME and ICE remain our favorite ideas in the group.”

CME Group closed on Friday at $60.48.

Latest Ratings for CME

DateFirmActionFromTo
Oct 2014CitigroupMaintainsNeutral
Oct 2014Deutsche BankMaintainsBuy
Oct 2014Bank of AmericaMaintainsNeutral

View More Analyst Ratings for CME
View the Latest Analyst Ratings

Posted-In: JefferiesAnalyst Color Price Target Analyst Ratings

 

Related Articles (CME)

Around the Web, We're Loving...

Get Benzinga's Newsletters